Literature DB >> 27656030

Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression.

Takashi Saito1, Yukio Matsuba1, Naomi Yamazaki1, Shoko Hashimoto1, Takaomi C Saido2.   

Abstract

UNLABELLED: Intraneuronal calcium stimulates the calpain-dependent conversion of p35 to p25, a CDK5 activator. It is widely believed that amyloid β peptide (Aβ) induces this conversion that, in turn, has an essential role in Alzheimer's disease pathogenesis. However, in vivo studies on p25 generation used transgenic mice overexpressing mutant amyloid precursor protein (APP) and presenilin (PS). Here, using single App knock-in mice, we show that p25 generation is an artifact caused by membrane protein overexpression. We show that massive Aβ42 accumulation without overexpression of APP or presenilin does not produce p25, whereas p25 generation occurred with APP/PS overexpression and in postmortem mouse brain. We further support this finding using mice deficient for calpastatin, the sole calpain-specific inhibitor protein. Thus, the intracerebral environment of the APP/PS mouse brain and postmortem brain is an unphysiological state. SIGNIFICANCE STATEMENT: We recently estimated using single App knock-in mice that accumulate amyloid β peptide without transgene overexpression that 60% of the phenotypes observed in Alzheimer's model mice overexpressing mutant amyloid precursor protein (APP) or APP and presenilin are artifacts (Saito et al., 2014). The current study further supports this estimate by invalidating key results from papers that were published in Cell These findings suggest that more than 3000 publications based on APP and APP/PS overexpression must be reevaluated.
Copyright © 2016 Saito et al.

Entities:  

Keywords:  Nav1.1; amyloid; calpain; p25

Mesh:

Substances:

Year:  2016        PMID: 27656030      PMCID: PMC5030353          DOI: 10.1523/JNEUROSCI.1907-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  24 in total

1.  Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice.

Authors:  Jiro Takano; Masanori Tomioka; Satoshi Tsubuki; Makoto Higuchi; Nobuhisa Iwata; Shigeyoshi Itohara; Masatoshi Maki; Takaomi C Saido
Journal:  J Biol Chem       Date:  2005-02-02       Impact factor: 5.157

2.  Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

Authors:  Holly Oakley; Sarah L Cole; Sreemathi Logan; Erika Maus; Pei Shao; Jeffery Craft; Angela Guillozet-Bongaarts; Masuo Ohno; John Disterhoft; Linda Van Eldik; Robert Berry; Robert Vassar
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

Review 3.  Calpain: new perspectives in molecular diversity and physiological-pathological involvement.

Authors:  T C Saido; H Sorimachi; K Suzuki
Journal:  FASEB J       Date:  1994-08       Impact factor: 5.191

4.  Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.

Authors:  Laure Verret; Edward O Mann; Giao B Hang; Albert M I Barth; Inma Cobos; Kaitlyn Ho; Nino Devidze; Eliezer Masliah; Anatol C Kreitzer; Istvan Mody; Lennart Mucke; Jorge J Palop
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

5.  Aβ secretion and plaque formation depend on autophagy.

Authors:  Per Nilsson; Krishnapriya Loganathan; Misaki Sekiguchi; Yukio Matsuba; Kelvin Hui; Satoshi Tsubuki; Motomasa Tanaka; Nobuhisa Iwata; Takashi Saito; Takaomi C Saido
Journal:  Cell Rep       Date:  2013-10-03       Impact factor: 9.423

6.  Single App knock-in mouse models of Alzheimer's disease.

Authors:  Takashi Saito; Yukio Matsuba; Naomi Mihira; Jiro Takano; Per Nilsson; Shigeyoshi Itohara; Nobuhisa Iwata; Takaomi C Saido
Journal:  Nat Neurosci       Date:  2014-04-13       Impact factor: 24.884

7.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

8.  Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation.

Authors:  Ikuo Ogiwara; Hiroyuki Miyamoto; Noriyuki Morita; Nafiseh Atapour; Emi Mazaki; Ikuyo Inoue; Tamaki Takeuchi; Shigeyoshi Itohara; Yuchio Yanagawa; Kunihiko Obata; Teiichi Furuichi; Takao K Hensch; Kazuhiro Yamakawa
Journal:  J Neurosci       Date:  2007-05-30       Impact factor: 6.167

Review 9.  Amyloid-ß-directed immunotherapy for Alzheimer's disease.

Authors:  L Lannfelt; N R Relkin; E R Siemers
Journal:  J Intern Med       Date:  2014-03       Impact factor: 8.989

10.  Nav1.1 haploinsufficiency in excitatory neurons ameliorates seizure-associated sudden death in a mouse model of Dravet syndrome.

Authors:  Ikuo Ogiwara; Takuji Iwasato; Hiroyuki Miyamoto; Ryohei Iwata; Tetsushi Yamagata; Emi Mazaki; Yuchio Yanagawa; Nobuaki Tamamaki; Takao K Hensch; Shigeyoshi Itohara; Kazuhiro Yamakawa
Journal:  Hum Mol Genet       Date:  2013-08-06       Impact factor: 6.150

View more
  45 in total

Review 1.  Calpain research for drug discovery: challenges and potential.

Authors:  Yasuko Ono; Takaomi C Saido; Hiroyuki Sorimachi
Journal:  Nat Rev Drug Discov       Date:  2016-11-11       Impact factor: 84.694

2.  Potential Alzheimer's Disease Therapeutics Among Weak Cysteine Protease Inhibitors Exhibit Mechanistic Differences Regarding Extent of Cathepsin B Up-Regulation and Ability to Block Calpain.

Authors:  Heather Romine; Katherine M Rentschler; Kaitlan Smith; Ayanna Edwards; Camille Colvin; Karen Farizatto; Morgan C Pait; David Butler; Ben A Bahr
Journal:  Eur Sci J       Date:  2017-10

Review 3.  Calpain-2 as a therapeutic target for acute neuronal injury.

Authors:  Yubin Wang; Xiaoning Bi; Michel Baudry
Journal:  Expert Opin Ther Targets       Date:  2017-11-28       Impact factor: 6.902

4.  Endoplasmic reticulum stress responses in mouse models of Alzheimer's disease: Overexpression paradigm versus knockin paradigm.

Authors:  Shoko Hashimoto; Ayano Ishii; Naoko Kamano; Naoto Watamura; Takashi Saito; Toshio Ohshima; Makoto Yokosuka; Takaomi C Saido
Journal:  J Biol Chem       Date:  2018-01-03       Impact factor: 5.157

5.  Temporal progression of Alzheimer's disease in brains and intestines of transgenic mice.

Authors:  Gunjan D Manocha; Angela M Floden; Nicole M Miller; Abbie J Smith; Kumi Nagamoto-Combs; Takashi Saito; Takaomi C Saido; Colin K Combs
Journal:  Neurobiol Aging       Date:  2019-06-13       Impact factor: 4.673

6.  Life-Course Contribution of Prenatal Stress in Regulating the Neural Modulation Network Underlying the Prepulse Inhibition of the Acoustic Startle Reflex in Male Alzheimer's Disease Mice.

Authors:  Zahra Jafari; Bryan E Kolb; Majid H Mohajerani
Journal:  Cereb Cortex       Date:  2020-01-10       Impact factor: 5.357

7.  Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation.

Authors:  Takashi Saito; Naomi Mihira; Yukio Matsuba; Hiroki Sasaguri; Shoko Hashimoto; Sneha Narasimhan; Bin Zhang; Shigeo Murayama; Makoto Higuchi; Virginia M Y Lee; John Q Trojanowski; Takaomi C Saido
Journal:  J Biol Chem       Date:  2019-07-04       Impact factor: 5.157

8.  Fisetin Reduces the Impact of Aging on Behavior and Physiology in the Rapidly Aging SAMP8 Mouse.

Authors:  Antonio Currais; Catherine Farrokhi; Richard Dargusch; Aaron Armando; Oswald Quehenberger; David Schubert; Pamela Maher
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-03-02       Impact factor: 6.053

Review 9.  Alzheimer's disease: experimental models and reality.

Authors:  Eleanor Drummond; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2016-12-26       Impact factor: 17.088

Review 10.  Tau-based therapies in neurodegeneration: opportunities and challenges.

Authors:  Chuanzhou Li; Jürgen Götz
Journal:  Nat Rev Drug Discov       Date:  2017-10-06       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.